The Brazil renal dialysis equipment market size was valued USD 1,984.19 million in 2019 and is estimated to reach USD XX million by 2027, growing at a CAGR of 5.4% during the forecast period (2020-2027).
Renal Dialysis is an artificial method of maintaining the chemical balance of the blood when the kidneys have failed. The renal dialysis equipment are the devices which are used for artificial blood purification of acute kidney injuries or end-stage renal disease. Increasing usage of these equipment owing to various factors in this region is expected to drive the Brazil renal dialysis equipment market.
With the rising number of End-stage renal disease (ESRD) cases, there is a need for dialysis, hence the number of dialysis centers are increasing. A predominant number of hemodialysis patients undergo treatment in dialysis centers. The rising health insurance market has driven the patients towards better medical care and further spending more on medical equipment.
Based on equipment type the Brazil renal dialysis equipment market is broadly segmented as hemodialysis equipment, Peritoneal Dialysis (PD) Equipment, Continuous Renal Replacement Therapy (CRRT) systems. Among all these hemodialysis equipment accounted for major share of about 58.14% in 2019, and is projected to grow at a high CAGR over the forecast period (2020-2027). Hemodialysis equipment is used in the treatment procedure and techniques of dialysis, fulfilling the role of the artificial kidney in the event of damage or deterioration of the organ.
Based on end users the Brazil renal dialysis equipment market is segmented into hospitals, in-clinic & dialysis centers, and homecare settings. Among all these hospitals accounted for major market share in 2019 and is projected to grow at a high CAGR of about 6.1% over the forecast period (2020-2027). The renal dialysis equipment in Brazilian hospitals is used to provide medical treatment to patients with chronic kidney disease and acute kidney injury, with a total of 309 participating centers operating in Brazil. Of these, around 47% of the centers are located in hospitals.
Market Dynamics
Drivers
- Increasing prevalence of chronic kidney diseases
- Rise in number of dialysis centers
Restraints
- Risks in hemodialysis treatment
- Rising cases of kidney transplantations
Increasing Prevalence of Chronic Kidney Diseases
Chronic kidney disease (CKD) represents a major challenge for Latin America (LA), due to its epidemic proportions and high burden to the population affected and to public health systems.
In 2016, Brazil had an estimated incidence rate of 194 cases of treated ESRD per one million population.
The prevalence of end-stage renal disease (ESRD) under renal replacement therapy (RRT) in Latin America increased from 119 patients per million population (pmp) in 1991 to 660 pmp in 2010 (hemodialysis (HD) 413 pmp, peritoneal dialysis (PD) 135 pmp, and LFG 111 pmp).
The annual incidence rate of patients with diabetic nephropathy was 79 pmp. The annual gross mortality rate was 18.2%. For prevalent patients, 92% were on hemodialysis and 8% on peritoneal dialysis, and 29,268 (24%) were on a waiting list of renal transplant
Hence, with a rising number of End-Stage Renal Disease (ESRD) cases in Brazil is leading to the growth of the market.
Competitive Landscape
The major players of the Brazil renal dialysis equipment market are Asahi Kasei Corporation, Baxter International, B. Braun, Fresenius Medical Care AG, Nipro Corporation, Nikkiso, NxStage Medical, Angiodynamics, and others. The product launches, collaboration, and product agreements, and other key developments are the dominating strategies adopted by the market players to enhance their product portfolio in the Brazil renal dialysis equipment market.
For instance, in October 2020, United States based privately held medical device company Diality, invested around USD 12.5 million in developing a portable haemodialysis system to address the unmet technology needs of the evolving dialysis industry.
Nipro Medical Corporation launched Cellentia®-H cellulose triacetate (CTA), single-use dialyzer at the 2017 ASN Kidney Week Conference. The Cellentia®-H is the newest addition to Nipro’s growing line of high-performance dialyzers. The Cellentia®-H dialyzer is indicated for all hemodialysis patients, especially those where conservative therapy is judged to be inadequate.
The Brazilian healthcare market is highly attractive and it has a huge market with increasing potential, for medical device manufacturers. Among the most populous nations of over 200 million people, Brazil's medical device industry opportunities are vast.
In Brazil, most of the dialysis centers use PD as an option for patients with no alternative vascular access for hemodialysis.
Counting on this, the market for PD in Brazil is highly adoptive by making PD more economically interesting to nephrologists, also better training for the Brazilian neurologist , by creating reference centers for PD training and many more.
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
